PAPER Hu H, Vervaeke K, Storm JF
SEARCH RESULTS
330978 RESULTS
PAPER Moyer JT, Danish SF
Stimulation-induced dyskinesias inform basal ganglia models and the mechanisms of deep brain stimulation.
J Neurosci. 2007 Feb 21;27(8):1799-800. PubMed: 17315340PAPER Boddaert N, Le Quan Sang KH, Rötig A, Leroy-Willig A, Gallet S, Brunelle F, Sidi D, Thalabard JC, Munnich A, Cabantchik ZI
Selective iron chelation in Friedreich ataxia: biologic and clinical implications.
Blood. 2007 Jul 1;110(1):401-8. PubMed: 17379741PAPER Durić G, Svetel M, Nikolaevic SI, Dragadević N, Gavrilović J, Kostić VS
[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
Vojnosanit Pregl. 2007 Jan;64(1):25-30. PubMed: 17304721PAPER Hodaie M, Neimat JS, Lozano AM
The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Neurosurgery. 2007 Jan;60(1):17-28; discussion 28-30. PubMed: 17228250PAPER Kazantsev AG, Hersch SM
Drug targeting of dysregulated transcription in Huntington's disease.
Prog Neurobiol. 2007 Nov;83(4):249-59. PubMed: 17379386PAPER Artacho-Pérula E, Insausti R
Quantitative estimations of the entorhinal cortex in Alzheimer's disease.
Anal Quant Cytol Histol. 2007 Feb;29(1):1-16. PubMed: 17375870PAPER Anand R, Seiberling M, Kamtchoua T, Pokorny R
Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.
Clin Pharmacokinet. 2007;46(4):351-8. PubMed: 17375985PAPER Wiener HW, Perry RT, Chen Z, Harrell LE, Go RC
A polymorphism in SOD2 is associated with development of Alzheimer's disease.
Genes Brain Behav. 2007 Nov;6(8):770-5. PubMed: 17376152PAPER Pogocki D, Ruman T, Danilczuk M, Celuch M, Wałajtys-Rode E
Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
Eur J Pharmacol. 2007 Jun 1;563(1-3):18-39. PubMed: 17376429PAPER Ren QG, Liao XM, Chen XQ, Liu GP, Wang JZ
Effects of tau phosphorylation on proteasome activity.
FEBS Lett. 2007 Apr 3;581(7):1521-8. PubMed: 17376439PAPER Kim Y, Olivi L, Cheong JH, Maertens A, Bressler JP
Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells.
Toxicol Appl Pharmacol. 2007 May 1;220(3):349-56. PubMed: 17376497PAPER Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, Van Nostrand WE
Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid.
J Neurosci. 2007 Mar 21;27(12):3057-63. PubMed: 17376966PAPER Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y, Krishnamurthy P, Herman M, Wang L, Schachter JB, Nelson RB, Lau LF, Duff KE
Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia.
J Neurosci. 2007 Mar 21;27(12):3090-7. PubMed: 17376970PAPER Łowicka E, Bełtowski J
Hydrogen sulfide (H2S)- the third gas of interest for pharmacologists.
Pharmacol Rep. 2007 Jan-Feb;59(1):4-24. PubMed: 17377202Current Filters
- Date Range : All x